A pivotal trial is a clinical investigation designed to provide the main evidence that a medical device is safe and effective for its intended use. It generally comes after early feasibility work has helped researchers settle the design, select suitable participants and decide which outcomes to measure.
For an implantable brain-computer interface, a pivotal investigation might assess whether people can communicate or control devices reliably over time while also tracking surgery-related risks, device problems and durability. The study design and number of participants depend on the device, its proposed use and the evidence regulators require; pivotal does not mean a fixed minimum sample size.
Investigators define success measures before collecting the main data. They also need procedures for reporting adverse events, accounting for missed visits and comparing results with an appropriate benchmark or control where possible. The FDA reviews the strength and relevance of the evidence rather than accepting a trial solely because it was called pivotal.
A company's announcement that it is planning a pivotal trial does not mean the study has begun, reached its goals or won approval. Check the trial registration, enrollment status, endpoints and published results before drawing conclusions about commercial readiness.